# A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients

> **NCT00679991** · PHASE1,PHASE2 · COMPLETED · sponsor: **Proteon Therapeutics** · enrollment: 66 (actual)

## Conditions studied

- Chronic Kidney Disease

## Interventions

- **DRUG:** PRT-201
- **DRUG:** PRT-201

## Key facts

- **NCT ID:** NCT00679991
- **Lead sponsor:** Proteon Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2015-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00679991

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00679991, "A Phase 1-2 Study of PRT-201 Administered in Chronic Kidney Disease (CKD) Patients". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00679991. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*